ORIONS Money Stocks

[LaJollaCA]

TPIV

ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934

TapImmune Inc. submitted an application under Rule 24b-2 requesting
confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed
on August 14, 2015.
Based on representations by TapImmune Inc. that this information qualifies as
confidential commercial or financial information under the Freedom of Information Act,
5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly
disclose it. Accordingly, excluded information from the following exhibit will not be
released to the public for the time period specified:
Exhibit 10.1 through July 21, 2020
For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:
Brent J. Field

http://quotemedia.10kwizard.com/cgi/convert/pdf/TPIV-20160204-CTORDER-0.pdf?pdf=1&repo=tenk&ipage=10711782&num=-2&pdf=1&xml=1&dn=2&quest=1&rid=23&dn=3